The Manila Times

Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Disease…

Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
The News-Herald

State Rep. Daniel Troy reflects on District 23 accomplishments, looks ahead

This is one in a series looking at what Northeast Ohio officials, communities, and agencies experienced in 2025 and what they ...
The Manila Times

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes ...
North Tama Telegraph

Property taxes, eminent domain debate to return in 2026 Iowa legislative session

Iowa lawmakers are heading into the 2026 legislative session with several new leaders – but many of the issues expected to ...